On December 5, 2023, FSD Pharma Inc closed the transaction. The transaction included participation from new investor Xorax Family Trust for 12 Class A shares for gross proceeds of CAD 22.80.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.475 CAD | -5.00% | -8.65% | -60.42% |
1st Jan change | Capi. | |
---|---|---|
-60.42% | 13.95M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- HUGE Stock
- News FSD Pharma Inc.
- FSD Pharma Inc. announced that it has received CAD 0.000046 million in funding